Embecta Corp. Logo

Embecta Corp.

Global producer of diabetes injection devices, like pen needles and syringes, for 30M+ people.

EMBC | NDAQ

Overview

Corporate Details

ISIN(s):
US29082K1051
LEI:
Country:
United States of America
Address:
1209 ORANGE STREET, 19801 WILMINGTON
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Embecta Corp. is a global medical device company focused on improving the lives of people with diabetes. Spun off from Becton, Dickinson and Company (BD) in 2022, the company leverages a 100-year legacy of innovation in insulin delivery. As a leading producer of diabetes injection devices, its product portfolio includes pen needles and insulin syringes that serve over 30 million people in more than 100 countries. Embecta is dedicated to developing and providing solutions for diabetes management, supported by educational resources on proper injection techniques.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Embecta Corp. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Embecta Corp.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Embecta Corp. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Noul Co., Ltd. Logo
AI-powered, automated point-of-care diagnostics for accessible global healthcare.
South Korea 376930
Nuwellis, Inc. Logo
Develops an ultrafiltration system to remove excess fluid from diuretic-resistant patients.
United States of America NUWE
Nyxoah SA Logo
Develops a mask-free, minimally invasive neurostimulation implant to treat Obstructive Sleep Apnea.
United States of America NYXH
OMNICELL, INC. Logo
Automating medication management for healthcare providers with robotics and intelligent software.
United States of America OMCL
ONCOSEM ONKOLOJİK SİSTEMLER SANAYİ VE TİCARET A.Ş. Logo
Manufactures automated systems & devices for safe, efficient oncology chemotherapy treatment.
Türkiye ONCSM
Develops photodisinfection therapies to combat antimicrobial resistance and prevent infections.
Canada OBI
Onward Medical N.V. Logo
Develops spinal stimulation therapies to restore movement for people with spinal cord injury.
Netherlands ONWD
Orchestra BioMed Holdings, Inc. Logo
Develops bioelectronic & drug/device therapies for hypertension and artery disease.
United States of America OBIO
Organogenesis Holdings Inc. Logo
Develops regenerative biomaterials for wound care, surgical, and sports medicine markets.
United States of America ORGO
Orthofix Medical Inc. Logo
Delivering musculoskeletal solutions like spinal hardware & biologics to global health providers.
United States of America OFIX

Talk to a Data Expert

Have a question? We'll get back to you promptly.